{"database": "lobbying", "table": "lobbying_activities", "rows": [[2145415, "9d7f5d0e-6243-46a2-acf2-27a6fa11a429", "Q2", "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES", 1524, "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO", 2018, "second_quarter", "MED", "Letter to Congress supporting the Food and Drug Administration's process related to a pending guidance entitled,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2018-07-16T14:44:41.947000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2145415"], "units": {}, "query_ms": 0.344960018992424, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}